Literature DB >> 11959581

A chemically modified tetracycline (CMT-3) is a new antifungal agent.

Yu Liu1, Maria E Ryan, Hsi-Ming Lee, Sanford Simon, George Tortora, Carol Lauzon, Michael K Leung, Lorne M Golub.   

Abstract

Several chemically modified tetracycline analogs (CMTs), which were chemically modified to eliminate their antibacterial efficacy, were unexpectedly found to have antifungal properties. Of 10 CMTs screened in vitro, all exhibited antifungal activities, although their efficacies varied. Among these compounds, CMT-315, -3, and -308 were found to be the most potent as antifungal agents. The MICs of CMT-3 against 47 strains of fungi in vitro were determined by using amphotericin B (AMB) and doxycycline as positive and negative controls, respectively. The MICs of CMT-3 were generally found to be between 0.25 and 8.00 microg/ml, a range that approximates the blood levels of this drug when administrated orally to humans. Of all the yeast species tested to date, Candida albicans showed the greatest sensitivity to CMT-3. The filamentous species most susceptible to CMT-3 were found to be Epidermophyton floccosum, Microsporum gypseum, Pseudallescheria boydii, a Penicillium sp., Scedosporium apiospermum, a Tricothecium sp., and Trichophyton rubrum. Growth inhibition of C. albicans by CMT-3, determined by a turbidity assay, indicated a 50% inhibitory concentration of 1 microg/ml. Thirty-nine strains, including 20 yeasts and 19 molds, were used to measure viability (the ability to grow after treatment with a drug) inhibition by CMT-3 and AMB. CMT-3 exhibited fungicidal activity against most of these fungi, especially the filamentous fungi. Eighty-four percent (16 of 19) of the filamentous fungi tested showed more than 90% inhibition of viability by CMT-3. In contrast, AMB showed fungicidal activity against all yeasts tested. However, most of the filamentous fungi (16 of 19) showed less than 50% inhibition of viability by AMB, indicating that AMB is fungistatic against most of these filamentous fungi. To begin to identify the sites in fungal cells affected by CMT-3, C. albicans and a Penicillium sp. were incubated with the compound at 35 degrees C, and then the fluorescence of CMT-3 was observed by confocal laser scanning electron microscopy. CMT-3 appeared to have widespread intracellular distribution throughout C. albicans and the Penicillium sp. The mechanisms of the antifungal activity of CMT-3 are now being explored.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959581      PMCID: PMC127171          DOI: 10.1128/AAC.46.5.1447-1454.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  Fungal infections in AIDS patients.

Authors:  B Dupont; J R Graybill; D Armstrong; R Laroche; J E Touzé; L J Wheat
Journal:  J Med Vet Mycol       Date:  1992

Review 2.  Antifungal treatment in patients with cancer.

Authors:  C Viscoli; E Castagnola; M Machetti
Journal:  J Intern Med Suppl       Date:  1997

3.  In vitro interaction between amphotericin B and azoles in Candida albicans.

Authors:  J A Vazquez; M T Arganoza; J K Vaishampayan; R A Akins
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions.

Authors:  H Ramos; E Valdivieso; M Gamargo; F Dagger; B E Cohen
Journal:  J Membr Biol       Date:  1996-07       Impact factor: 1.843

Review 5.  Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.

Authors:  L M Golub; H M Lee; M E Ryan; W V Giannobile; J Payne; T Sorsa
Journal:  Adv Dent Res       Date:  1998-11

6.  Development of resistance in candida isolates from patients receiving prolonged antifungal therapy.

Authors:  P Fan-Havard; D Capano; S M Smith; A Mangia; R H Eng
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 7.  Lipid formulations of amphotericin B: clinical efficacy and toxicities.

Authors:  A Wong-Beringer; R A Jacobs; B J Guglielmo
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

8.  Disseminated candidiasis due to amphotericin B-resistant Candida albicans.

Authors:  J Conly; R Rennie; J Johnson; S Farah; L Hellman
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

9.  Fungal Pseudoallescheria boydii lung infiltrates unresponsive to amphotericin B in leukaemic patients.

Authors:  M Walsh; L White; K Atkinson; A Enno
Journal:  Aust N Z J Med       Date:  1992-06

10.  Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats.

Authors:  C Tasset; V Preat; A Bernard; M Roland
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

View more
  6 in total

1.  Doxycycline hydrogels as a potential therapy for ocular vesicant injury.

Authors:  Marion K Gordon; Andrea Desantis; Manjeet Deshmukh; Carl Jeffrey Lacey; Rita A Hahn; John Beloni; Sivanaga S Anumolu; John J Schlager; Michael A Gallo; Donald R Gerecke; Ned D Heindel; Kathy K H Svoboda; Michael C Babin; Patrick J Sinko
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

Review 2.  Antimicrobial aromatic polyketides: a review of their antimicrobial properties and potential use in plant disease control.

Authors:  Jae Woo Han; Gyung Ja Choi; Beom Seok Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-10-28       Impact factor: 3.312

3.  Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis.

Authors:  Rupali Agnihotri; Sumit Gaur
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

4.  A Novel Analysis via Micro-CT Imaging Indicates That Chemically Modified Tetracycline-3 (CMT-3) Inhibits Tooth Relapse after Orthodontic Movement: A Pilot Experimental Study.

Authors:  Giovanni Modesto Vieira; Denise Pinheiro Falcao; Sormani Bento Fernandes de Queiroz; Valthierre Nunes de Lima; Ricardo Bentes de Azevedo; Valdenize Tiziane; Heitor Moreno; Rivadavio Amorim
Journal:  Int J Dent       Date:  2019-04-01

5.  Reliable Target Prediction of Bioactive Molecules Based on Chemical Similarity Without Employing Statistical Methods.

Authors:  Abed Forouzesh; Sadegh Samadi Foroushani; Fatemeh Forouzesh; Eskandar Zand
Journal:  Front Pharmacol       Date:  2019-07-26       Impact factor: 5.810

6.  CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects.

Authors:  Florencia González-Lizárraga; Diego Ploper; César L Ávila; Sergio B Socías; Mauricio Dos-Santos-Pereira; Belén Machín; Elaine Del-Bel; Patrick Pierre Michel; Lía I Pietrasanta; Rita Raisman-Vozari; Rosana Chehín
Journal:  Sci Rep       Date:  2020-11-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.